Titanium dioxide (E171)

This is the strongest reason titanium dioxide gets more scrutiny than many other food additives. On 6 May 2021, EFSA concluded E171 could no longer be considered safe as a food additive because a genotoxicity concern could not be excluded, and the EU transition period ended on 7 August 2022. That is not the same as proof of harm at ordinary intake, though. WHO/JECFA in November 2023 and the UK Committee on Toxicity in 2024 took a more reassuring view of current dietary exposure, so the regulatory story is precautionary but not unanimous.

This is the core scientific dispute. Cell and animal studies do report DNA-damage signals under some conditions, which is why EFSA treated the issue seriously. But the evidence is messy: test materials vary, nanoparticle methods are imperfect, and later reviews including the 2023 JECFA reassessment did not find convincing evidence that representative food-grade titanium dioxide clearly causes genotoxicity through the diet. The current state is not "proved safe" and not "proved to damage DNA in everyone" either. The honest read is unresolved concern rather than a settled verdict.

Most authorities agree on the first half of this claim: oral absorption of food-grade titanium dioxide appears low, and human oral bioavailability is thought to be very low. The reason concern remains is the second half. Animal distribution studies and some human tissue data suggest a small absorbed fraction can cross the gut and remain in tissues for some time. That does not mean large systemic exposure or established clinical harm from food use, but it does explain why regulators pay attention even though most of what is eaten is not absorbed.

This is biologically plausible, but the evidence in people is thin. Reviews of animal, organoid, and cell studies describe possible effects on gut barrier function, microbiota interactions, immune signalling, and low-grade intestinal inflammation. That is enough to keep the question open, especially for people with existing gut disease, but it is not enough to say ordinary dietary E171 clearly worsens IBS, Crohn's disease, or ulcerative colitis in humans. At the moment this is mainly a mechanistic and preclinical concern, not a well-proven clinical effect.

Cancer headlines around titanium dioxide often blur together different exposure routes. IARC's Group 2B classification concerns inhaled titanium dioxide dust, not normal oral exposure from food. For dietary E171, JECFA's 2023 reassessment said there are no epidemiological studies that allow conclusions about human health effects, and it did not find convincing carcinogenicity in adequately conducted long-term animal studies using representative material. That does not close the book forever, but it does mean the claim that eating E171 is known to cause cancer runs ahead of the current evidence.

Recent exposure reviews and meta-analytic work suggest children can have higher body-weight-adjusted intake of food-grade titanium dioxide than adults. That does not prove harm by itself, but it does matter for risk assessment because the foods most likely to contain E171 have historically included sweets, cake decorations, chewing gum, and some supplements, which children may consume more often relative to body weight. In practical terms, the additive is more relevant to high-exposure subgroups than to adults eating it only occasionally.

Titanium dioxide is worth understanding, but it is still mostly a colour additive sitting inside a bigger food pattern. Removing E171 from a confectionery-heavy diet does not make that diet healthy, and a small residual exposure from an occasional tablet coating or cake decoration is unlikely to be the main driver of long-term risk. The bigger levers remain overall dietary quality, fibre intake, energy balance, and how much ultra-processed food you eat in total. In LP terms: this ingredient can matter, but it rarely matters more than the broader pattern it comes packaged in.